Search Results

Overview

Uniprot IDO43866
Protein NameCD5 antigen-like
Gene NameCD5L
OrganismHomo sapiens

Kla Sites from experimental identification

Position Flanking peptide
299 SPSFRDRKCYGPGVG
56 CDDGWDIKDVAVLCR

Function

Secreted protein that acts as a key regulator of lipid synthesis: mainly expressed by macrophages in lymphoid and inflamed tissues and regulates mechanisms in inflammatory responses, such as infection or atherosclerosis. Able to inhibit lipid droplet size in adipocytes. Following incorporation into mature adipocytes via CD36-mediated endocytosis, associates with cytosolic FASN, inhibiting fatty acid synthase activity and leading to lipolysis, the degradation of triacylglycerols into glycerol and free fatty acids (FFA). CD5L-induced lipolysis occurs with progression of obesity: participates in obesity-associated inflammation following recruitment of inflammatory macrophages into adipose tissues, a cause of insulin resistance and obesity-related metabolic disease. Regulation of intracellular lipids mediated by CD5L has a direct effect on transcription regulation mediated by nuclear receptors ROR-gamma (RORC). Acts as a key regulator of metabolic switch in T-helper Th17 cells. Regulates the expression of pro-inflammatory genes in Th17 cells by altering the lipid content and limiting synthesis of cholesterol ligand of RORC, the master transcription factor of Th17-cell differentiation. CD5L is mainly present in non-pathogenic Th17 cells, where it decreases the content of polyunsaturated fatty acyls (PUFA), affecting two metabolic proteins MSMO1 and CYP51A1, which synthesize ligands of RORC, limiting RORC activity and expression of pro-inflammatory genes. Participates in obesity-associated autoimmunity via its association with IgM, interfering with the binding of IgM to Fcalpha/mu receptor and enhancing the development of long-lived plasma cells that produce high-affinity IgG autoantibodies (By similarity). Also acts as an inhibitor of apoptosis in macrophages: promotes macrophage survival from the apoptotic effects of oxidized lipids in case of atherosclerosis (PubMed:24295828). Involved in early response to microbial infection against various pathogens by acting as a pattern recognition receptor and by promoting autophagy (PubMed:16030018, PubMed:24223991, PubMed:24583716, PubMed:25713983). Promotes recovery from acute kidney injury (AKI) by accumulating on necrotic cell debris within the kidney proximal tubules following AKI and interacting with HAVCR1 expressed on the surface of injured kidney tubular epithelial cells (PubMed:26726878). This enhances HAVCR1-mediated phagocytosis of intraluminal necrotic debris and contributes to kidney tissue repair (PubMed:26726878). Also enhances necrotic debris uptake by kidney macrophages in a HAVCR1-independent manner (By similarity)

Protein Sequence

10 MALLFSLILA 20 ICTRPGFLAS 30 PSGVRLVGGL 40 HRCEGRVEVE 50 QKGQWGTVCD 60 DGWDIKDVAV 70 LCRELGCGAA 80 SGTPSGILYE 90 PPAEKEQKVL 100 IQSVSCTGTE 110 DTLAQCEQEE 120 VYDCSHDEDA 130 GASCENPESS 140 FSPVPEGVRL 150 ADGPGHCKGR 160 VEVKHQNQWY 170 TVCQTGWSLR 180 AAKVVCRQLG 190 CGRAVLTQKR 200 CNKHAYGRKP 210 IWLSQMSCSG 220 REATLQDCPS 230 GPWGKNTCNH 240 DEDTWVECED 250 PFDLRLVGGD 260 NLCSGRLEVL 270 HKGVWGSVCD 280 DNWGEKEDQV 290 VCKQLGCGKS 300 LSPSFRDRKC 310 YGPGVGRIWL 320 DNVRCSGEEQ 330 SLEQCQHRFW 340 GFHDCTHQED VAVICSG

Gene Ontology

Classification GO ID Description
Cellular Component GO:0072562 blood microparticle
Cellular Component GO:0009986 cell surface
Cellular Component GO:0005737 cytoplasm
Cellular Component GO:0005576 extracellular region
Cellular Component GO:0005615 extracellular space
Cellular Component GO:0005886 plasma membrane
Biological Process GO:0006915 apoptotic process
Biological Process GO:0006968 cellular defense response
Biological Process GO:0002376 immune system process
Biological Process GO:0006954 inflammatory response
Biological Process GO:0030449 regulation of complement activation

Reference

[1] Hong H, Chen X, Wang H, Gu X, Yuan Y et al.. Global profiling of protein lysine lactylation and potential target modified protein analysis in hepatocellular carcinoma.. Proteomics 23(9):e2200432. 2023 May. PMID: 36625413.